These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 7324454)

  • 1. [Current trends in the treatment of chronic glomerulonephritis].
    Belovezhdov N; Altŭnkova I; Neshev Kh; Robeva R; Gruev I
    Vutr Boles; 1981; 20(5):54-64. PubMed ID: 7324454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of diffuse glomerulonephritis in systemic lupus erythematosus with a combination of anticoagulants, corticosteroids and immunosuppressors].
    Belovezhdov N
    Vutr Boles; 1985; 24(1):40-9. PubMed ID: 4024608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Possibilities of combined treatment of diffuse collagenous glomerulonephritis].
    Belovezhdov N; Tsekova D; Dzherasi R; Gruev I; Kiperova B
    Vutr Boles; 1982; 21(5):25-34. PubMed ID: 7164403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of diffuse membranous glomerulonephritis with a combination of anticoagulants and corticosteroids].
    Belovezhdov N
    Vutr Boles; 1984; 23(5):59-67. PubMed ID: 6523843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of diffuse glomerulonephritis in adults with Schönlein-Henoch disease using a combination of anticoagulants, corticosteroids and immunosuppressants].
    Belovezhdov N
    Vutr Boles; 1986; 25(2):21-5. PubMed ID: 3716373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Survival of patients with diffuse glomerulonephritis in disseminated lupus erythematosus treated with a combination of anticoagulants, corticosteroids and immunosuppressants].
    Belovezhdov N; Dimitrova V
    Vutr Boles; 1987; 26(1):21-7. PubMed ID: 3590722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Controlled therapeutic trial in IgA glomerulonephritis].
    Belovezhdov N; Robeva R
    Vutr Boles; 1982; 21(3):49-53. PubMed ID: 7051564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].
    Müller V; Natusch R; Göbel U; Laske HR; Sperschneider H; Pap I; Sinn W; Koall W; Achenbach H; Tredt HJ
    Z Urol Nephrol; 1985 Jan; 78(1):39-55. PubMed ID: 3976309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crescentic lupus glomerulonephritis.
    Yeung CK; Wong KL; Wong WS; Ng MT; Chan KW; Ng WL
    Clin Nephrol; 1984 May; 21(5):251-8. PubMed ID: 6733993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW; Branten AJ; Wetzels JF;
    Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of chronic glomerulonephritis with high doses of intravenous immunoglobulin].
    Belovezhdov N; Monova D; Altŭnkova I; Robeva R
    Vutr Boles; 1990; 29(1):59-68. PubMed ID: 2396419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the filtration function of the kidneys during the treatment of chronic glomerulonephritis].
    Riabov SI; Stavskaia VV; Kozlov VV; Kucher AG
    Ter Arkh; 1994; 66(8):52-7. PubMed ID: 7985156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
    Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V
    Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL; Shkerina LI; Shilov EM
    Klin Med (Mosk); 2005; 83(10):48-50. PubMed ID: 16320847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of heparin in the treatment of idiopathic rapidly progressive glomerulonephritis.
    Suc JM; Durand D; Conte J; Mignon-Conte M; Orfila C; That HT; Duchet JP
    Clin Nephrol; 1976 Jan; 5(1):9-13. PubMed ID: 1248188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is it justifiable to use antiplatelet drugs as a universal protection in patients with chronic glomerular damage?].
    Duclos J
    Rev Med Chil; 1993 Mar; 121(3):286-91. PubMed ID: 8248641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differentiated pathogenetic therapy of glomerulonephritis].
    Belovezhdov N
    Ter Arkh; 1987; 59(8):38-40. PubMed ID: 3686444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.